Issue 004 · Tuesday, March 24, 2026 · OR Edge Morning Report

The patient was prepped. The surgeon was scrubbed. A South Florida ASC was minutes away from starting a routine vein ablation when the billing coordinator flagged the case.

The prior authorization was not on file.

The case did not happen.

That scenario is no longer an edge case. As of January 19, 2026, Florida became part of the CMS five-year prior authorization demonstration covering five high-volume ASC procedures. If your billing workflow has not been updated since last year, you are operating with a process that is already obsolete.

And in a year when your reimbursement went up 2.6% against a 3.3% cost increase, a $4,700 cancellation is not an inconvenience. It is an EBITDA event (EBITDA: your center's real operational profit, before accounting and financing costs are factored in).

Protect your block time before your next Florida case hits the board: Calculate

Your ASC's Cancellation Leakage — Free Link: https://maroon-lyndsie-39.tiiny.site

Let's get into it!

Florida: The 2026 CMS Testing Ground: Why your 2025 billing workflow is officially obsolete

Florida is not alone in this, but it is where the clock started first.

CMS launched a five-year prior authorization demonstration covering ten states. Florida, along with California, Tennessee, Pennsylvania, Maryland, Georgia, and New York, entered Phase 1 on January 19, 2026. Texas, Arizona, and Ohio followed in Phase 2 on February 16, 2026.

The five procedure categories targeted are those CMS identified as high risk for cosmetic rather than medically necessary use:

For South Florida ASCs performing vein ablations, this is the procedure to watch first. It carries the highest utilization volume of the five and was the primary driver behind CMS creating this demonstration.

Here is what the demonstration actually requires: participation is technically voluntary; however, ASCs that bypass the prior authorization process will have applicable claims subjected to prepayment medical review, with potential denials for ineligible services.

Voluntary in name. Mandatory in practice.

The Margin Context

This is not just a compliance story. It is a margin story.

Prior authorization requirements now cover 46% of all ASC cases, creating cash flow delays that erode your EBITDA even when claims are ultimately paid. Add the reimbursement gap, rising supply costs, and anesthesia pressure, and every unprotected case on your schedule is a compounding liability.

For an ASC collecting $3 million per month, a single compliance failure can eliminate the entire monthly revenue gain from the CMS payment update.

Your surgeons are credentialed. Your OR is equipped. Your billing team is working. But if your scheduler does not have a prior authorization workflow built specifically around these five procedures, the revenue leak is already happening.

The January 19th Recovery Audit: Five questions for your team this week!

1. Do your schedulers know which cases require prior authorization before they hit the board?

Vein ablation, blepharoplasty, Botox, panniculectomy, and rhinoplasty all require a PAR (Prior Authorization Request; your team's formal submission to Medicare before the procedure date) submitted to your MAC (Medicare Administrative Contractor; the regional company that processes Medicare claims on CMS's behalf; Florida's MAC is First Coast Service Options) before the service date. Providers in Florida could begin submitting requests on January 5, 2026, for dates of service on or after January 19, 2026. Build at least a two-week submission lead time into your scheduling workflow.

2. Is your billing team tracking PAR approval windows?

Each approved prior authorization is valid for 120 days from the decision date. If your team is not tracking decision dates and expiration windows, you are creating a secondary cancellation risk for returning patients. A returning patient whose original PAR has expired needs a new submission before their follow-up procedure, not on the morning of.

3. Are you ready for the higher-acuity procedures coming to your schedule?

CMS added 547 procedures to the ASC Covered Procedures List for 2026, including cardiac ablations, lumbar spinal fusions, and vascular procedures previously performed only in hospital settings. Your prior authorization workflow was built for your current case mix. Audit it now, before the new case mix arrives and exposes the gaps.

4. Does your pre-op intake specifically name the anticoagulants your patients are actually taking?

Patients arriving for vein ablations are frequently on anticoagulation therapy. Asking "Are you on blood thinners?" is not enough. Name Eliquis, Xarelto, Pradaxa, Coumadin, and Plavix directly on your intake form. One line change. Significant impact on your day-of cancellation rate.

5. Do you have a documented response protocol for a denied or delayed PAR decision?

A denial is not a dead end; it is a resubmission trigger. Providers may resubmit a prior authorization request an unlimited number of times upon receipt of a non-affirmative decision. If your team does not have a documented resubmission workflow, a denial becomes a cancellation by default. That is a process failure, not a Medicare failure.

→ Want to calculate how Pre-op Authorizations-related cancellations are affecting your ACS’s revenue? The free Pre-Op Cancellation Cost Calculator runs your real figures in under 60 seconds: Pre-op Cancellation Cost-Calculator

Curated intelligence from the perioperative space this week.

The WISeR Overlap: The prior authorization demonstration runs concurrently with the WISeR Model (Wasteful and Inappropriate Service Reduction; a separate CMS initiative using AI and machine learning to flag procedures for prepayment review across six states). If your center operates across multiple states, your compliance exposure is layered, and each state carries its own effective date and MAC contact.

Surgical Smoke Update: Twenty states now have mandatory surgical smoke evacuation laws. If your state is not yet one of them, watch your 2026 legislative calendar. This is moving faster than most administrators anticipated.

The GLP-1 Gap: Your intake form likely screens for Ozempic. Does it screen for Tirzepatide, the active ingredient in Mounjaro and Zepbound? Same aspiration risk profile. Different brand name. Patients do not connect the two. Your pre-op team is the last line of detection before that patient reaches your OR.

I have stood and witnessed in the holding area when a case gets pulled for a documentation miss.

The surgeon does not say much. The patient, who fasted since midnight, arranged a ride and took the day off work, is trying to understand what happened. The administrator is looking at an empty OR that still carries its full overhead, whether a case runs in it or not.

Clinical readiness and revenue integrity are the same discipline. We just were not trained to see them that way.

Build the workflow before the next case hits the board.

See you next Tuesday at 6:00 AM.

Brief comment before closing out this edition!

Know an ASC administrator or OR manager who needs this? Forward this issue or send it directly here: oredgemorningreport.com/subscribe Free. No fluff. Written from the floor through a Perioperative RN, who has been living the same as you every single day!

What is the one prior authorization workflow gap your team is still working to close? Reply to this email or leave a comment below!

Do the audit this week, before you need to!

The centers navigating 2026 are the ones that built their systems before the crisis arrived. Those that didn't are rebuilding them now, under pressure, with compromised leverage, and a full schedule on the board.

You have time right now. Use it!

Sources & Methodology

All data cited in this issue is sourced from verifiable published references:

OR Edge Morning Report maintains a strict data integrity standard. Every statistic published in this newsletter is verified against its source before publication. If you identify a discrepancy, reply directly to this email.

If this landed with you — forward it to one independent ASC administrator or surgical director in your network who is navigating anesthesia coverage right now. They need this more than they know.

Reply with what you are seeing on the anesthesia front at your center. I read every response.

See you next Tuesday at 0600.

Yetsenia Tyson, RN, Founder, Haleris

Publisher, OR Edge Morning Report